Skip to content

Coca-cola's Clinical Effects on Gastric Phytobezoars

The Randomized Controlled Trial of Coca-cola's Clinical Effects on Gastric Phytobezoars

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05645263
Enrollment
492
Registered
2022-12-09
Start date
2017-01-01
Completion date
2021-12-31
Last updated
2022-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bezoars

Keywords

RCT, Bezoars, Cola, lithotripsy, Gastroscopy

Brief summary

Consecutive patients suffering from gastric phytobezoars were divided into 3 groups (Group 1, Group 2 and Group 3) according to the phytobezoars' formation time and each group was further subdivided into control and intervention group according to whether Coca-Cola was admitted. All patients in intervention group dieted Coca-Cola whereas patients in control group refused to drink Coca-Cola and had willing to receive the emergently gastric fragmentation.

Detailed description

Consecutive patients were enrolled and were divided into Group 1(the formation time of phytobezoars was less than 7 days), Group 2(the formation time of phytobezoars was from 7 days to 14 days) and Group 3 (the formation time of phytobezoars was more than 14 days) according to the formation time of phytobezoars and each group was subdivided into control group (who refused to diet Coca-Cola and chose emergent fragmentation with gastroscopy) and intervention Group (who had a willing to diet Coca-Cola) from 1st Jan, 2017 to 1st Dec 2021. The current protocol was approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University (QYFYWZLL 26293). The patients in intervention group all dieted Coca-Cola to treat gastric phytobezoars, 250ml-500ml/2 h till to sleeping time according to personal health conditions and life habits. Pay more attention to the stools and assess if the bezoars had excreted. The Coca-Cola dieting period of intervention group 1 was 3 days, intervention group 2 was 5 days and intervention group 3 was 7 days. The patients would go through an endoscopy once the Coca-Cola dieting therapy was over. The patients who chose emergently endoscopic fragmentation was enrolled in control Group. All patients endorsed the digital informed consent and bring the medical records before endoscopy. Statistical analysis was performed with SPSS version 22(IBM, Inc. Armonk, NY, USA). ANOVA or independent samples t-test was used for analysis of continuous variables. P \< 0.05 was taken as statistical meaning.

Interventions

OTHERdieting Coca-cola

The patients all dieted Coco-cola to treat gastric phytobezoars, 250ml-500ml/2 h till to sleeping time according to the health conditions and life habits. Pay more attention to the stools and assess if the bezoars had excreted. The dieting Coco-cola period of group A is 3 days, group B is 5 days and group C is 7 days.

Sponsors

The Affiliated Hospital of Qingdao University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcome assessor don't know which group the patient is in.

Intervention model description

All patients were divided into 3 groups according to bezoar formation time combined with the willing of the patients. Patients whose phytobezoar formation time was less than a week in Group 1 , phytobezoar formation time between 1week and 2 weeks in Group2 , phytobezoar formation time longer than 2 weeks in Group 3. Every group was subdivided into intervention and control group according to whether Coco-cola was dieted.

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed by abdominal CT or gastroscope; * years older than 12; * no contraindications; * have willingness to diet Caco-cola to treat gastric bezoars; * choose the emergent endoscopy whose bezoar formation time are more than 2 weeks;

Exclusion criteria

* Gastroscopy contraindications; * choose the emergent endoscopy whose bezoar formation time are shorter than 2 weeks; * years younger than 12 years;

Design outcomes

Primary

MeasureTime frameDescription
Medical expenseup to 48 monthsThe medical expense of each patient was added together and compared among the groups
Operation timeup to 48 monthsThe operation time of each patient was recorded and compared among the groups
Dissolution rateup to 48 monthsAll the patients will go through a repeated endoscopy to ascertain if the phytobezoars has disappeared or shrinked and record the findings
Gastric ulcer rateup to 48 monthsAll the patients will go through a repeated endoscopy to ascertain if there was ulcers located in the stomach and record the findings

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026